TP 8452

Drug Profile

TP 8452

Alternative Names: Atorvastatin/TP-452 - Thetis; DPA-statin combo - Thetis; TP 452/atorvastatin - Thetis; TP-8452

Latest Information Update: 13 Aug 2015

Price : $50

At a glance

  • Originator Thetis Pharmaceuticals
  • Class Amides; Antihyperlipidaemics; Fluorobenzenes; Heptanoic acids; Omega 3 fatty acids; Pyrroles; Small molecules
  • Mechanism of Action HMG-CoA reductase inhibitors; PCSK9 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Dyslipidaemias

Most Recent Events

  • 13 Aug 2015 Preclinical trials in Dyslipidaemias in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top